Canary Capital Registers Staked Injective ETF in Delaware

Canary Capital has officially registered a staking-enabled Injective ETF in Delaware, highlighting the firm’s commitment to innovative crypto exchange-traded funds (ETFs) within the U.S. This registration marks a significant step as Canary Capital continues its development of staking-focused investment products. While the impact on Injective’s market remains limited due to this exploratory registration, it signals a broader trend in the adoption of staking by ETF providers.